Stock Research: Raia Drogasil

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Raia Drogasil

BOVESPA:RADL3 BRRADLACNOR0
12
  • Value
    38
  • Growth
    55
  • Safety
    Safety
    19
  • Combined
    14
  • Sentiment
    26
  • 360° View
    360° View
    12
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Raia Drogasil S/A is a Brazilian company focused on the retail sale of pharmaceutical and cosmetic products. It operates in the retail pharmacy industry, selling branded and generic medications, OTC medications, and personal hygiene products. The company primarily operates in Brazil, across all federal units. In the last fiscal year, the company had a market cap of $4,152 million, profits of $1,871 million, and revenue of $6,292 million, with 64758 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 12 (better than 12% compared with alternatives), overall professional sentiment and financial characteristics for the stock Raia Drogasil are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Raia Drogasil. The consolidated Growth Rank has a good rank of 55, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 55% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 19 means that the share price of Raia Drogasil is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 81% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 38, which means that the company has a riskier financing structure than 62% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 26, indicating professional investors are more pessimistic about the stock than for 74% of alternative investment opportunities. ...read more

more
Index
BOVESPA
Independent Boards Growth Markets
Renewables Users
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
19 19 7 11
Growth
55 55 97 83
Safety
Safety
38 57 50 48
Sentiment
26 46 77 85
360° View
360° View
12 37 60 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
34 44 45 26
Opinions Change
50 35 50 64
Pro Holdings
n/a 55 73 93
Market Pulse
38 67 84 68
Sentiment
26 46 77 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
19 19 7 11
Growth
55 55 97 83
Safety Safety
38 57 50 48
Combined
14 32 50 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
19 29 15 32
Price vs. Earnings (P/E)
48 49 25 36
Price vs. Book (P/B)
22 22 11 20
Dividend Yield
26 22 15 15
Value
19 19 7 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
94 92 90 75
Profit Growth
21 30 71 78
Capital Growth
86 82 65 69
Stock Returns
11 23 81 19
Growth
55 55 97 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
30 38 40 38
Refinancing
57 62 57 53
Liquidity
32 44 43 60
Safety Safety
38 57 50 48

Similar Stocks

Discover high‑ranked alternatives to Raia Drogasil and broaden your portfolio horizons.

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Lojas Renner

BOVESPA:LREN3
Country: Brazil
Industry: Apparel Retail
Size: Medium
Full Stock Analysis

Suzano

BOVESPA:SUZB3
Country: Brazil
Industry: Paper Products
Size: X-Large
Full Stock Analysis

Localiza Rental Car

BOVESPA:RENT3
Country: Brazil
Industry: Trucking
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.